Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/10/2019
SIETES contiene 92826 citas

 
 
 1 a 20 de 99 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Anderson TS, Jing B, Auerbach A, Wray CM, Lee S, Boscardin WJ, Fung K, Ngo S, Silvestrini M, Steinman MA. Clinical outcomes after intensifying antihypertensive medication regimens among older adults at hospital discharge. JAMA Intern Med 2019:19 de agosto. [Ref.ID 103182]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Reaven PD, Emanuele NV, Wiitala WL, Bahn GD, Reda DJ, McCarren M, Duckworth WC, Hayward RD, VADT Investigators. Intensive glucose control in patients with type 2 diabetes - 15-year follow-up. N Engl J Med 2019;380:6 de junio. [Ref.ID 103135]
3.Enlace a cita originalTiene citas relacionadas Cita con resumen
Navarese EP, Robinson JG, Kowatewski M, Kotodziejczak M, Andreotti F, Bliden K, Tantry U, Kubica J, Raggi P, Gurbel PA. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering. A systematic review and meta-analysis. JAMA 2018;319:17 de abril. [Ref.ID 102784]
4. Cita con resumen
Young LA, Buse JB, Weaver MA, Vu MB, Mitchell M, Blakeney T, Grimm K, Rees J, Niblock F, Donahue KE, for the Monitor Trial Group. Glucose self-monitoring in non-insulin-treated patients with type 2 diabetes in primary care settings. A randomized trial. JAMA Intern Med 2017;177:920-9. [Ref.ID 102017]
5. Cita con resumen
Tsai W-C, Wu H-Y, Peng Y-S, Yang J-Y, Chen HY, Chiu Y-L, Hsu S-P, Ko M-J, Pai M-F, Tu Y-K, Hung K-Y, Chien K-L. Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic review and meta-analysis. JAMA Intern Med 2017;177:792-9. [Ref.ID 101619]
6. Cita con resumen
Whittle J. Blood pressure variability and cardiovascular risk. BMJ 2016;354:i4190. [Ref.ID 100604]
7. Cita con resumen
Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, McMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahími K, Perkovic V, Rodgers A. Effect of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet 2016;387:435-43. [Ref.ID 100094]
8. Cita con resumen
Gerstein HC, Miller ME, Ismail-Beigi F, Largay J, McDonald C, Lochnan HA, Booth GL, for the ACCORD Study Group. Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial. Lancet 2014;384:1936-41. [Ref.ID 98368]
9.Enlace a cita original
Yan YL, Qiu B, Hu LJ, Jing XD, Liu YJ, Deng SB, Du JL, She Q. Efficacy and safety evaluation of intensive statin therapy in older patients with coronary heart disease: a systematic review and meta-analysis. Eur J Clin Pharmacol 2013;69:2001-9. [Ref.ID 96637]
10. Cita con resumen
Slomski A. Avoiding hypoglycemia at all costs is crucial for some with diabetes. JAMA 2013;309:2536-7. [Ref.ID 95732]
11.Tiene citas relacionadas
Frontera JA. Blood pressure in intracerebral hemorrhage - How low should we go?. N Engl J Med 2013;368:2426-7. [Ref.ID 95703]
12.Tiene citas relacionadas Cita con resumen
Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, Lindley R, Robinson T, Lavados P, Neal B, Hata J, Arima H, Parsons M, Li Y, Wang JC, Heritier S, Li Q, Woodward M, Simes RJ, Davis SM, Chalmers J, for the INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013;368:2355-65. [Ref.ID 95698]
13. Cita con resumen
Anónimo. HbA1c targets in type 2 diabetes: guidelines and evidence. Drug Ther Bull 2013;51:42-5. [Ref.ID 95196]
14. Cita con resumen
Perkovic V, Heerspink HL, Chalmers J, Woodward M, Jun M, Li Q, MacMahon SC, Cooper ME, Hamet P, Marre M, Mogensen CE, Poulter N, Mancia G, Cass A, Patel A, Zoungas S. Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int 2013;83:517-23. [Ref.ID 95115]
15.Tiene citas relacionadas Cita con resumen
Nissen SE. Cardiovascular effects of diabetes drugs: emerging from the dark ages. Ann Intern Med 2012;157:671. [Ref.ID 94015]
18.Tiene citas relacionadas Cita con resumen
McBrien K, Rabi DM, Campbell N, Bamieh L, Clement F, Hemmelgam BR, Tonelli M, Leiter LA, Klarenbach SW, Manns BJ. Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 2012;172:1296-303. [Ref.ID 93794]
19. Cita con resumen
Fan VS, Gaziano JM, Lew R, Bourbeau J, Adams SG, Leatherman S, Thwin SS, Huang GD, Robbins R, Sriram PS, Sharafkhaneh A, Mador MJ, Sarosi GM, Panos RJ, Rastogi P, Wagner TH, Mazzuca SA, Shannon C, Colling C, Liang MH, Stoller JK, Fiore L, Niewoehner DE. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med 2012;156:673-83. [Ref.ID 92952]
20. Cita con resumen
The DCCT/EDIC Research Group. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 2011;365:2366-76. [Ref.ID 91982]
Seleccionar todas
 
 1 a 20 de 99 siguiente >>